Display options
Share it on

Thyroid Res. 2013 Sep 11;6(1):11. doi: 10.1186/1756-6614-6-11.

Negative correlation between bone mineral density and TSH receptor antibodies in long-term euthyroid postmenopausal women with treated Graves' disease.

Thyroid research

Monica A Ercolano, Monica L Drnovsek, Maria C Silva Croome, Monica Moos, Ana M Fuentes, Fanny Viale, Ulla Feldt-Rasmussen, Alicia T Gauna

Affiliations

  1. Endocrinology Division, Hospital Ramos Mejía, Buenos Aires, Argentina. [email protected].

PMID: 24020400 PMCID: PMC3847206 DOI: 10.1186/1756-6614-6-11

Abstract

BACKGROUND: Thyrotoxicosis is a cause of secondary osteoporosis. High concentrations of triiodotironine (T3) in Graves' disease stimulate bone turnover, but it is unclear if euthyroidism will always normalize bone metabolism. Thyrotropin (TSH) is known to affect directly the bone metabolism through the TSH receptor and TSH receptor antibodies (TRAb) may have an important role in bone turn-over.The aim of our study was to determine, in pre and postmenopausal euthyroidism patients with previous overt hyperthyroidism due to Graves' disease the bone mineral density (BMD) as well as factors that could affect BMD in each group, including TRAb.

METHODS: Cross-sectional, non-interventional study. Fifty-seven patients with previous hyperthyroidism due to Graves' disease (premenopausal: 30, postmenopausal: 27) that remained euthyroid for at least 6 months prior to study were included and compared with fifty- two matched respective controls. Thyrotoxine (T4), TSH, TRAb and BMD were measured.

RESULTS: Only euthyroid postmenopausal patients with a history of hyperthyroidism due to Graves' disease showed lower whole body BMD than matched controls. The BMD expressed as Z-score was less in whole body and lumbar spine in postmenopausal in relation to premenopausal women with previous overt hyperthyroidism due to Graves' disease.In the postmenopausal patients, the Z-score of lumbar spine BMD correlated negatively with TRAb (r = -0,53, p < 0.008), positively with the time of evolution of the disease (r = +0.42, p < 0.032) and positively with the time of euthyroidism (r = + 0.50, p < 0.008), but neither with serum T4 nor TSH. In a multiple regression analysis TRAb was the only significant independent variable in relation to lumbar spine BMD (F = 3. 90, p < 0.01).

CONCLUSIONS: In euthyroid women with a history of Graves' hyperthyroidism, BMD was only affected in the postmenopausal group. The negative correlation of Z-score of lumbar spine BMD with TRAb suggests that this antibody may affect the bone metabolism.

References

  1. Thyroid. 1994 Fall;4(3):319-26 - PubMed
  2. J Intern Med. 1995 Mar;237(3):241-7 - PubMed
  3. J Clin Endocrinol Metab. 2009 Mar;94(3):927-35 - PubMed
  4. J Clin Endocrinol Metab. 1997 Jun;82(6):1989-94 - PubMed
  5. Cell. 2003 Oct 17;115(2):151-62 - PubMed
  6. Clin Endocrinol (Oxf). 1994 Oct;41(4):421-4 - PubMed
  7. Bone Miner. 1993 Apr;21(1):1-8 - PubMed
  8. J Bone Miner Res. 1999 Oct;14(10):1664-71 - PubMed
  9. Endocr Rev. 1988 Feb;9(1):106-21 - PubMed
  10. Metabolism. 1986 Jan;35(1):71-4 - PubMed
  11. Clin Endocrinol (Oxf). 1998 Mar;48(3):285-90 - PubMed
  12. Endocrinology. 2005 Apr;146(4):2077-84 - PubMed
  13. J Clin Endocrinol Metab. 2008 Mar;93(3):861-8 - PubMed
  14. J Clin Invest. 2004 Jun;113(11):1589-95 - PubMed
  15. J Endocrinol Invest. 1997 Sep;20(8):452-61 - PubMed
  16. Thyroid. 1993 Spring;3(1):17-23 - PubMed
  17. Endocrinology. 1994 Jan;134(1):169-76 - PubMed
  18. Clin Endocrinol (Oxf). 1997 Aug;47(2):215-21 - PubMed
  19. Clin Endocrinol (Oxf). 1995 Sep;43(3):339-45 - PubMed
  20. J Clin Endocrinol Metab. 1996 Aug;81(8):2986-93 - PubMed
  21. Endocr Rev. 1986 Nov;7(4):379-408 - PubMed
  22. Thyroid. 2002 May;12(5):411-9 - PubMed
  23. Trends Endocrinol Metab. 2003 Oct;14(8):356-64 - PubMed
  24. J Clin Endocrinol Metab. 2013 Jun;98(6):2247-55 - PubMed
  25. Arch Intern Med. 1986 Jan;146(1):48-53 - PubMed
  26. Maturitas. 2001 Jul 25;39(1):19-27 - PubMed
  27. Thyroid. 1996 Jun;6(3):161-8 - PubMed
  28. Clin Endocrinol (Oxf). 2004 Oct;61(4):466-72 - PubMed
  29. Thyroid. 2008 Apr;18(4):455-60 - PubMed
  30. Ann Intern Med. 1994 Jan 1;120(1):8-11 - PubMed
  31. N Engl J Med. 1995 Mar 23;332(12):767-73 - PubMed
  32. Nutr Metab (Lond). 2010 Sep 01;7:72 - PubMed
  33. Singapore Med J. 2006 Nov;47(11):947-50 - PubMed
  34. Thyroid. 2000 Apr;10(4):341-8 - PubMed
  35. Osteoporos Int. 1998;8(5):455-9 - PubMed
  36. Osteoporos Int. 2006;17(7):1103-10 - PubMed
  37. Eur J Endocrinol. 2008 Jan;158(1):69-75 - PubMed
  38. Clin Endocrinol (Oxf). 1983 May;18(5):439-46 - PubMed
  39. Medicina (B Aires). 1992;52(3):207-12 - PubMed
  40. Endocr Rev. 1994 Dec;15(6):788-830 - PubMed
  41. Endocrinol Metab Clin North Am. 1990 Mar;19(1):35-63 - PubMed
  42. J Clin Endocrinol Metab. 2000 Nov;85(11):4157-61 - PubMed
  43. J Thyroid Res. 2012;2012:182176 - PubMed
  44. Clin Endocrinol (Oxf). 1999 Feb;50(2):171-6 - PubMed
  45. J Clin Endocrinol Metab. 1992 Dec;75(6):1531-4 - PubMed
  46. Am J Med. 1991 Jul;91(1):5-14 - PubMed

Publication Types